This research study aims to investigate the use of circulating tumor DNA (ctDNA) monitoring to detect early signs of cancer recurrence in patients with triple-negative breast cancer (TNBC) after standard treatment. TNBC is aggressive and has a higher risk of recurrence, often detected only after symptoms appear. This study will monitor ctDNA levels through blood samples collected during and after adjuvant therapy. If ctDNA is not detected, participants will continue monitoring. If ctDNA is detected, the study offers an investigational treatment, datopotamab deruxtecan (Dato-DXd), to address this potential recurrence risk. Participation in this study will help determine if ctDNA monitoring can improve the early detection of recurrence and potentially lead to better treatment strategies and outcomes for patients with TNBC in the future.

Do you or your child have hidradenitis suppurativa? Would you be interested in hearing more about a clinical study on hidradenitis suppurativa? If so, you may be able to participate in a research study to find out how effective and safe the study medication Ruxolitinib is in patients with hidradenitis suppurativa.

Do you speak Spanish or identify as Hispanic or Latino and have cancer? You can help improve cancer care by sharing your experience. We need patients to complete a one-time survey about your health, background, and cancer treatment. Your input is important and can help others receive better care. Participation involves only a one-time survey, with no required medical tests. ¿Es usted un adulto hispano, latino o de habla hispana con cáncer? Puede ayudar a mejorar la atención del cáncer al compartir su experiencia. Le pedimos a los pacientes que completen una encuesta una sola vez sobre su salud, antecedentes y atención médica durante o después del tratamiento. Su voz es importante y puede ayudar a que otros reciban mejor atención. La participación consiste únicamente en una encuesta, sin pruebas médicas obligatorias.

Do you have cancer that has spread to your bones (high-risk bone metastases)? Is your cancer not causing any pain, or asymptomatic? If so, you may be able to take part in a research study comparing the standard approach with the standard approach plus radiation therapy to see if it's better at lowering bone metastases-related complications.

By joining, you'll share important health information in a secure research registry to help scientists: -Understand how the immune system reacts to food -Improve diagnosis and treatment -Develop prevention strategies and new therapies

In this study, we're interested in understanding couples' experiences with using ChatGPT and each other for emotional support. We are recruiting couples to take part in a paid virtual study! This study includes 21 days of short online surveys sent via email, and you can earn up to $34 each for your participation.

Researchers are trying to find out if they can slow the growth of prostate cancer by adding green tea to patients treatment. Researchers are also trying to find out if this could be better or worse than usual care patients get.

Do you have advanced Stage III or IV Head and Neck Cancer? You might be able to join a research study. We are looking at new treatments compared to the usual care for your type of cancer.

We are doing a study to see if a new treatment, called INO-3107, can help people with recurrent respiratory papillomatosis (RRP). We want to find out if this treatment works well and if it helps patients need fewer surgeries in the future.

To identify gaps in services and/or barriers to diagnosis and care for patients with tick-borne illnesses living in NC.